Preliminary Outcomes of Sacral Neuromodulation Applications; Tertiary-Center Experience in Turkey

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06098963

Enrollment

Registered

2023-10-25

Start date

2017-01-01

Completion date

2023-01-01

Last updated

2023-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacral Neuromodulation

Keywords

Sacral neuromodulation, Overactive bladder, Urinary incontinence, Fecal incontinence, Lower urinary tract dysfunction

Brief summary

to report our patients' outcomes of SNM in tertiary health centres in Turkey

Detailed description

We retrospectively analyzed 18 patients who underwent SNM for urinary or bowel dysfunction between 2017 and 2022 in our clinic. We excluded 2 patients due to non-effective responses after the test period. After local ethics committee approval was obtained from our institute (Number and date: 21-12.1T/14). Patient characteristics and demographic data including age, gender, indications to the SNM, age at diagnosis, and comorbidities were collected from our Hospital patients' record system. Urinary functions were evaluated by the ICIQ-SF questionnaire form. Patients' diagnosis, implantation duration, complications, and improvement of symptoms were recorded.

Interventions

DEVICEsacral neuromodulation

sacra neuromodulator implantation outcomes

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Patients diagnosed with urinary incontinence * Patients diagnosed with faecal incontinence * Patients diagnosed with interstitial cystitis

Exclusion criteria

* Presence of urinary infection * Presence of previous incontinence surgery * Presence of 2nd motor neurone disease * Inability of detrusor muscle contraction activity * Previous radical cystoprostatectomy history * Presence of bladder outlet obstruction

Design outcomes

Primary

Measure	Time frame	Description
Recovery of urinary or fecal incontinence	1 year	Significant decrease in urinary or fecal incontinence episode

Secondary

Measure	Time frame	Description
increase in the score of ICIQ-SF questionnaire	1 year	improvement of quality of life and increase in the score of ICIQ-SF questionnaire

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026